the number of studies (prostate cancer cases) included in each meta-analysis were 42 (7,481) igf-i; 10 (923) igf-ii; 3 (485) igfbp-1; 5 (577) igfbp-2; 29 (6,541) igfbp-3; and 11 (3,545) igf-1:igfbp-3 ratio.